Spectrum Pharmaceuticals
SPPI
#8445
Rank
C$0.29 B
Marketcap
C$1.42
Share price
0.00%
Change (1 day)
15.32%
Change (1 year)

Revenue for Spectrum Pharmaceuticals (SPPI)

Revenue in 2023 (TTM): C$34.84 Million

According to Spectrum Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is C$35.54 Million. In 2022 the company made a revenue of C$13.72 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spectrum Pharmaceuticals from 1996 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) C$34.84 M153.92%
2022 C$13.72 M
2021 N/A
2020 N/A
2019 N/A-100%
2018 C$0.14 B-7.72%
2017 C$0.16 B-17.99%
2016 C$0.19 B-12.73%
2015 C$0.22 B4.01%
2014 C$0.21 B30.68%
2013 C$0.16 B-16.02%
2012 C$0.19 B0.65%
2011 C$0.19 B164.95%
2010 C$74.08 M85.17%
2009 C$40 M
2007 C$7.65 M
2002 C$3.74 M5618.41%
2001 C$0.06 M1457129.96%
2000 C$0 M-100%
1999 C$0.28 M-37.46%
1998 C$0.46 M7.61%
1997 C$0.42 M4.31%
1996 C$0.41 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Teva Pharmaceutical Industries
TEVA
C$23.17 B 65,102.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Seagen
SGEN
C$3.17 B 8,840.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
C$16.09 M-54.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$13.90 B 39,022.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$66.35 B 186,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$60.56 B 170,303.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$77.87 B 218,999.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
C$127.30 B 358,052.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$86.73 B 243,928.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$58.51 B 164,511.05%๐Ÿ‡ฌ๐Ÿ‡ง UK